Health Committee (Sejm)

Health Committee (Sejm)
Name	Health Committee (Sejm)
Native name	Komisja Zdrowia
Chamber	Sejm
Legislature	Parliament of Poland
Type	Standing committee
Jurisdiction	Health policy, public health, healthcare legislation
Formed	1919

Health Committee (Sejm) is a standing committee of the Sejm of the Parliament of Poland responsible for scrutinizing legislation and policy related to public health, healthcare, and related institutions. The committee reviews draft laws, monitors executive implementation, and conducts inquiries involving ministries, agencies, and external stakeholders such as professional associations and patient organizations. It has served as a forum linking parliamentary oversight with ministries, expert bodies, and international organizations.

History

The committee traces roots to parliamentary commissions established after the reconstitution of Poland in 1918, paralleling developments in the Second Polish Republic, the Sanation period, and the post-World War II transformations under the Polish People's Republic. During the Solidarity era and the transition following the Fall of Communism in Eastern Europe, the committee adapted to new frameworks such as the 1997 Constitution of Poland and reforms inspired by memberships in the European Union and interactions with the World Health Organization. Its institutional evolution reflects responses to crises including the 2009 flu pandemic, the SARS-CoV-2 pandemic, and reforms associated with the National Health Fund and the Ministry of Health (Poland). The committee has interacted with the Constitutional Tribunal (Poland) on matters of statutory compatibility and with the Supreme Audit Office (Poland) on expenditure reviews.

Composition and Membership

Membership is drawn from deputies serving in the Sejm representing parties such as Law and Justice, Civic Platform, Polish People's Party, The Left, and smaller factions or independents. The committee’s composition reflects proportional representation from parliamentary clubs and includes chairpersons, vice-chairs, and secretaries. Deputies with backgrounds in institutions like the National Medical Chamber, Polish Nurses Association, Medical University of Warsaw, Jagiellonian University Medical College, and regional medical centers often serve. External cooperation involves experts from bodies such as the Polish Academy of Sciences, European Centre for Disease Prevention and Control, European Medicines Agency, and representatives from NGOs including Polish Red Cross and patient advocacy groups. Subcommittee structures have included working groups on pharmaceuticals, public health, and medical workforce drawn from deputies representing constituencies including Warsaw, Kraków, Gdańsk, and Łódź.

Powers and Responsibilities

Under parliamentary rules codified in the Sejm standing orders and shaped by the 1997 Constitution of Poland, the committee examines bills referred by the Marshal of the Sejm, issues opinions on government draft legislation from the Council of Ministers, and initiates legislative proposals by deputies. It summons ministers such as the Minister of Health (Poland) and officials from the National Health Fund to provide evidence, and it may propose amendments affecting statutes like the Health Care Institutions Act and the Pharmaceutical Law. The committee contributes to ratification reviews when treaties touch on public health obligations such as agreements with the European Union or multilateral instruments coordinated by the World Health Organization. It can commission audits, request reports from the Chancellery of the Sejm, and refer matters to investigative commissions or the State Tribunal when legal accountability issues arise.

Legislative Activities and Reports

The committee produces reasoned opinions, legislative reports, and draft amendments during plenary stages of laws including reforms to the National Health Fund, hospital financing, and pharmaceutical reimbursement lists. It has handled high-profile legislative items like amendments to the Patient Rights and Patient Ombudsman Act, regulations affecting the Medical Tribunal, and provisions implementing EU directives on medicines and medical devices administered by the European Commission. The committee’s reports have informed debates on vaccination policies during the COVID-19 pandemic, antimicrobial resistance strategies linked to the European Centre for Disease Prevention and Control, and workforce planning tied to curricula at institutions such as the Medical University of Gdańsk and the Medical University of Łódź. It frequently collaborates with committees such as the Committee on Social Policy and Family and the Committee on Science and Education on cross-cutting bills.

Interaction with Government and Stakeholders

Regular interlocutors include the Minister of Health (Poland), directors of the National Health Fund, chiefs of regional Voivodeship health departments, and representatives from professional bodies like the Polish Chamber of Physicians and Dentists. The committee holds hearings with stakeholders from hospitals like the Central Clinical Hospital of the Medical University of Warsaw, pharmaceutical firms operating under regulatory oversight by the Office for Registration of Medicinal Products, and NGOs such as Doctors Without Borders (Médecins Sans Frontières) in Poland. It engages with international partners including the World Health Organization Regional Office for Europe, the Organisation for Economic Co-operation and Development, and parliamentary counterparts in forums like the Interparliamentary Union. Civil society participation from groups such as the Federation for Medical Education and patient coalitions shapes consultations and amendments.

Notable Chairpersons and Milestones

Notable chairpersons have included deputies who later served in executive roles at the Ministry of Health or in regulatory agencies and who influenced major reforms connected to the National Health Fund and hospital restructuring. Milestones include legislative overhauls of hospital financing, enactment of the Pharmaceutical Law amendments, parliamentary responses to the 2009 flu pandemic and the COVID-19 pandemic, and oversight inquiries that led to changes in procurement procedures aligned with European Public Procurement Law. The committee’s investigative work has prompted administrative reforms and informed Poland’s positions in EU health policy negotiations such as those involving EMA procedures and cross-border healthcare directives.

Category:Sejm committees Category:Health policy in Poland